It's an alternative media publication, unbiased and unvarnished, not beholden to corporate advertisers like our MSM that often serves as a public mouthpiece for the BP (among other criminal enterprises) protection racket.
Billion dollar agencies involved in corrupt practices are well-funded and savvy enough to hide their tracks so well it could take decades to uncover, provided your media outlet has the resources to fund investigative work by independent reporters, since the well-funded MSM would never bite the hand that bribes them. Unless the truth leaks from an inside source, say like from one of the couple dozen FDA scientists who resigned a decade ago in protest over endemic corruption within the US FDA, it will be extremely difficult to uncover the corruption.
But you can make an intelligent assumption based on their behaviors, known sources of revenue and their motives and the agency's responses to trials and results in key situations and how their decisions affect their benefactors and the public.
In the near future we will also be able to compare how other FDA equivalents in other countries respond to the positive results shown by this drug as compared to the US FDA from which we can draw more accurate conclusions about the alleged impropriety of the US FDA.
Considering most of the rest of the world looks up to the US FDA for guidance and precedent, if another country in that position approves leronlimab ahead of the US, that says a ton about the undue influence of other entities, who should have NO say in approval/assessment decisions within the agency, and of the level of corruption that would need to be present to allow it.
Billion dollar agencies involved in corrupt practices are well-funded and savvy enough to hide their tracks so well it could take decades to uncover, provided your media outlet has the resources to fund investigative work by independent reporters, since the well-funded MSM would never bite the hand that bribes them. Unless the truth leaks from an inside source, say like from one of the couple dozen FDA scientists who resigned a decade ago in protest over endemic corruption within the US FDA, it will be extremely difficult to uncover the corruption.
But you can make an intelligent assumption based on their behaviors, known sources of revenue and their motives and the agency's responses to trials and results in key situations and how their decisions affect their benefactors and the public.
In the near future we will also be able to compare how other FDA equivalents in other countries respond to the positive results shown by this drug as compared to the US FDA from which we can draw more accurate conclusions about the alleged impropriety of the US FDA.
Considering most of the rest of the world looks up to the US FDA for guidance and precedent, if another country in that position approves leronlimab ahead of the US, that says a ton about the undue influence of other entities, who should have NO say in approval/assessment decisions within the agency, and of the level of corruption that would need to be present to allow it.
2
